Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2018) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 7.422 Q1 | 254 | 25 | 76 | 8872 | 1519 | 75 | 19.91 | 354.88 |  |
| 2 | Medicinal Research Reviews | journal | 2.528 Q1 | 150 | 56 | 105 | 12882 | 962 | 104 | 9.68 | 230.04 | |
| 3 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.261 Q1 | 70 | 4 | 20 | 784 | 111 | 9 | 6.43 | 196.00 |  |
| 4 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.736 Q2 | 82 | 14 | 45 | 2732 | 146 | 45 | 2.90 | 195.14 | |
| 5 | Progress in Medicinal Chemistry | journal | 1.230 Q1 | 38 | 6 | 17 | 1127 | 48 | 4 | 1.82 | 187.83 |  |
| 6 | Pharmacology and Therapeutics | journal | 3.586 Q1 | 233 | 160 | 392 | 29808 | 4172 | 392 | 9.64 | 186.30 | |
| 7 | Drug Resistance Updates | journal | 4.319 Q1 | 132 | 18 | 70 | 3179 | 983 | 70 | 12.31 | 176.61 | |
| 8 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 |  |
| 9 | Current Medicinal Chemistry | journal | 0.918 Q2 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | |
| 10 | Journal of Receptor, Ligand and Channel Research | journal | 0.203 Q3 | 13 | 2 | 6 | 231 | 4 | 6 | 1.00 | 115.50 |  |
| 11 | Advanced Therapeutics | journal | 39 | 53 | 0 | 5982 | 0 | 0 | 0.00 | 112.87 |  | |
| 12 | Food and Drug Law Journal | journal | 0.231 Q3 | 23 | 19 | 74 | 2066 | 45 | 71 | 0.53 | 108.74 | |
| 13 | Cellular and Molecular Life Sciences | journal | 3.006 Q1 | 261 | 291 | 892 | 31340 | 6199 | 883 | 7.30 | 107.70 |  |
| 14 | Expert Opinion on Therapeutic Targets | journal | 1.470 Q1 | 106 | 91 | 359 | 9798 | 1568 | 333 | 4.30 | 107.67 | |
| 15 | Current Drug Metabolism | journal | 0.544 Q3 | 122 | 116 | 261 | 12267 | 638 | 240 | 2.38 | 105.75 | |
| 16 | Current Pharmaceutical Design | journal | 0.703 Q2 | 183 | 567 | 1815 | 57632 | 4871 | 1663 | 2.46 | 101.64 | |
| 17 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | |
| 18 | Issues in Toxicology | book series | 0.145 Q4 | 18 | 46 | 150 | 4530 | 60 | 36 | 0.43 | 98.48 | |
| 19 | Current Drug Targets | journal | 0.825 Q2 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | |
| 20 | Current Pharmacology Reports | journal | 0.803 Q2 | 35 | 42 | 115 | 4016 | 320 | 115 | 2.29 | 95.62 | |
| 21 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.484 Q1 | 150 | 283 | 496 | 26823 | 2148 | 489 | 4.45 | 94.78 | |
| 22 | Current Cancer Drug Targets | journal | 0.875 Q2 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | |
| 23 | Pharmacological Research | journal | 1.781 Q1 | 169 | 345 | 904 | 31951 | 4950 | 836 | 5.42 | 92.61 | |
| 24 | Neurotherapeutics | journal | 2.565 Q1 | 136 | 92 | 252 | 8483 | 1460 | 233 | 5.29 | 92.21 | |
| 25 | Current Topics in Pharmacology | journal | 0.137 Q4 | 8 | 11 | 26 | 994 | 7 | 26 | 0.13 | 90.36 |  |
| 26 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.896 Q2 | 100 | 116 | 405 | 10206 | 1345 | 380 | 3.42 | 87.98 | |
| 27 | Current Molecular Pharmacology | journal | 0.774 Q2 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | |
| 28 | Antiviral Chemistry and Chemotherapy | journal | 0.349 Q3 | 59 | 19 | 30 | 1552 | 37 | 27 | 1.70 | 81.68 | |
| 29 | Expert Review of Vaccines | journal | 1.603 Q1 | 105 | 102 | 358 | 8283 | 1412 | 327 | 4.12 | 81.21 | |
| 30 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 Q2 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | |
| 31 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | |
| 32 | Expert Opinion on Therapeutic Patents | journal | 1.018 Q1 | 88 | 78 | 326 | 6056 | 1139 | 320 | 3.76 | 77.64 | |
| 33 | Vaccines | journal | 2.136 Q1 | 85 | 81 | 150 | 6256 | 848 | 145 | 4.94 | 77.23 | |
| 34 | Pharmacognosy Reviews (discontinued) | journal | 0.767 Q2 | 68 | 30 | 66 | 2310 | 261 | 65 | 4.00 | 77.00 | |
| 35 | Molecular Diagnosis and Therapy | journal | 1.069 Q1 | 68 | 62 | 168 | 4756 | 486 | 163 | 3.16 | 76.71 | |
| 36 | Trends in Pharmacological Sciences | journal | 4.586 Q1 | 244 | 93 | 284 | 7123 | 3018 | 250 | 9.24 | 76.59 | |
| 37 | Pharmacology Biochemistry and Behavior | journal | 0.924 Q2 | 148 | 117 | 455 | 8733 | 1300 | 451 | 2.72 | 74.64 | |
| 38 | Neuropharmacology | journal | 1.780 Q1 | 191 | 500 | 1254 | 37062 | 5581 | 1232 | 4.41 | 74.12 | |
| 39 | Drug Discovery Today | journal | 2.248 Q1 | 215 | 215 | 576 | 15826 | 4269 | 545 | 7.04 | 73.61 | |
| 40 | CNS and Neurological Disorders - Drug Targets | journal | 0.747 Q2 | 96 | 87 | 433 | 6391 | 937 | 373 | 2.32 | 73.46 | |
| 41 | Biochemical Pharmacology | journal | 1.483 Q1 | 220 | 391 | 788 | 28104 | 3629 | 746 | 4.93 | 71.88 | |
| 42 | Expert Opinion on Biological Therapy | journal | 1.133 Q1 | 102 | 154 | 460 | 11044 | 1661 | 435 | 3.58 | 71.71 | |
| 43 | Expert Review of Precision Medicine and Drug Development | journal | 0.355 Q3 | 16 | 39 | 92 | 2753 | 115 | 75 | 1.25 | 70.59 | |
| 44 | Expert Opinion on Pharmacotherapy | journal | 0.866 Q2 | 93 | 213 | 696 | 15010 | 2012 | 652 | 2.80 | 70.47 | |
| 45 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | |
| 46 | Vascular Pharmacology | journal | 1.277 Q1 | 108 | 75 | 294 | 5237 | 1126 | 292 | 3.36 | 69.83 | |
| 47 | Drugs in Context | journal | 0.921 Q2 | 36 | 46 | 43 | 3211 | 126 | 41 | 1.04 | 69.80 | |
| 48 | Current Vascular Pharmacology | journal | 0.605 Q2 | 69 | 106 | 251 | 7332 | 481 | 202 | 1.90 | 69.17 | |
| 49 | Behavioural Pharmacology | journal | 0.782 Q2 | 87 | 79 | 243 | 5412 | 489 | 236 | 1.86 | 68.51 | |
| 50 | British Journal of Pharmacology | journal | 2.665 Q1 | 244 | 332 | 1046 | 22073 | 6539 | 1007 | 6.24 | 66.48 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data